Spaventi S - Search Results

1

Human lung cancers growing on extracellular matrix: expression of oncogenes and growth factors.

Pavelic K, Antonic M, Pavelic L, Pavelic J, Pavelic Z, Spaventi S. Pavelic K, et al. Among authors: spaventi s. Anticancer Res. 1992 Nov-Dec;12(6B):2191-6. Anticancer Res. 1992. PMID: 1363516

2

Growth factors in human tumors.

Kruslin B, Levanat S, Baltić V, Milković D, Pavelić J, Spaventi R, Spaventi S, Pavelić K. Kruslin B, et al. Among authors: spaventi s, spaventi r. Res Exp Med (Berl). 1989;189(2):91-9. doi: 10.1007/BF01851259. Res Exp Med (Berl). 1989. PMID: 2657914

3

Prognostic significance of transforming growth factor alpha TGF-alpha) in human lung carcinoma: an immunohistochemical study.

Pecur L, Kapitanovic S, Sonicki Z, Pavicic F, Spaventi S, Gluckman JL, Stambrook PJ, Pavelic ZP, Spaventi R, Pavelic K. Pecur L, et al. Among authors: spaventi s, spaventi r. Anticancer Res. 1994 Nov-Dec;14(6B):2839-43. Anticancer Res. 1994. PMID: 7872728 Clinical Trial.

4

Evidence for a role of EGF receptor in the progression of human lung carcinoma.

Pavelic K, Banjac Z, Pavelic J, Spaventi S. Pavelic K, et al. Among authors: spaventi s. Anticancer Res. 1993 Jul-Aug;13(4):1133-7. Anticancer Res. 1993. PMID: 8394672

5

Molecular genetics of malignant insulinoma.

Pavelic K, Hrascan R, Kapitanovic S, Vranes Z, Cabrijan T, Spaventi S, Korsic M, Krizanac S, Li YQ, Stambrook P, Gluckman JL, Pavelic ZP. Pavelic K, et al. Among authors: spaventi s. Anticancer Res. 1996 Jul-Aug;16(4A):1707-17. Anticancer Res. 1996. PMID: 8712689

6

Concomitant point mutation of tumor suppressor gene p53 and oncogene c-N-ras in malignant neuroendocrine pancreatic tumor.

Hrasćan R, Pavelić K, Pavicić D, Krizanac S, Stajcer-Sittić V, Pecur L, Spaventi S, Klimpfinger M, Pavelić J. Hrasćan R, et al. Among authors: spaventi s. Anticancer Res. 1996 Nov-Dec;16(6B):3761-6. Anticancer Res. 1996. PMID: 9042254

7

Insulin-like growth factor family and combined antisense approach in therapy of lung carcinoma.

Pavelić J, Pavelić L, Karadza J, Krizanac S, Unesić J, Spaventi S, Pavelić K. Pavelić J, et al. Among authors: spaventi s. Mol Med. 2002 Mar;8(3):149-57. Mol Med. 2002. PMID: 12142546 Free PMC article.

8

The consequences of insulin-like growth factors/receptors dysfunction in lung cancer.

Pavelic J, Krizanac S, Kapitanovic S, Pavelic L, Samarzija M, Pavicic F, Spaventi S, Jakopovic M, Herceg-Ivanovi Z, Pavelic K. Pavelic J, et al. Among authors: spaventi s. Am J Respir Cell Mol Biol. 2005 Jan;32(1):65-71. doi: 10.1165/rcmb.2004-0232OC. Epub 2004 Oct 28. Am J Respir Cell Mol Biol. 2005. PMID: 15514114

9

High c-erbB-2 protein level in colorectal adenocarcinomas correlates with clinical parameters.

Kapitanovic S, Spaventi R, Poljak L, Kapitanovic M, Pavelic ZP, Gluckman JL, Spaventi S, Pavelic K. Kapitanovic S, et al. Among authors: spaventi s, spaventi r. Cancer Detect Prev. 1994;18(2):97-101. Cancer Detect Prev. 1994. PMID: 7912991

10

Immunohistochemical detection of TGF-alpha, EGF-R, c-erbB-2, c-H-ras, c-myc, estrogen and progesterone in benign and malignant human breast lesions: a concomitant expression.

Spaventi R, Kamenjicki E, Pecina N, Grazio S, Grazio S, Pavelic J, Kusic B, Cvrtila D, Danilovic Z, Spaventi S, et al. Spaventi R, et al. Among authors: spaventi s. In Vivo. 1994 Mar-Apr;8(2):183-9. In Vivo. 1994. PMID: 7919121

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

60 results

Search Page

Filters